Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

September 26, 2003

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions
Vision Loss PartialHemianopiaHemianopia HomonymousQuadrantanopiaStroke, Ischemic
Interventions
OTHER

Training in the Blind Field

A computer software and chin-rest necessary to perform visual training will be loaned to each subject to be used at home. Subjects will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion, the presence of motion, or the orientation of a visual stimulus (either a small cloud of dots or bars) located at a predetermined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. Subjects will train daily (about 40-60 minutes total), 5 to 7 days per week for at least 3 and up to 12 months at a time.

OTHER

Training in the Sighted Field

This training will take place in lab at the University of Rochester Medical Center. Subject will perform one daily training session, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion, the presence of motion, or the orientation of a visual stimulus (either a small cloud of dots or bars) located at a predetermined location in the visual field. The computer program will automatically create a record of patient performance during each training session. Subjects will train daily (about 30-40 minutes total), 5 to 7 days per week for at 7 - 14 days.

Trial Locations (1)

14642

Flaum Eye Institute, University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of Rochester

OTHER

NCT05098236 - Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage | Biotech Hunter | Biotech Hunter